Acquired immunodeficiency syndrome-associated lymphomas are efficiently lysed through complement-dependent cytotoxicity and antibody-dependent cellular cytotoxicity by rituximab-Reference-Cited by-同舟云学术

Acquired immunodeficiency syndrome-associated lymphomas are efficiently lysed through complement-dependent cytotoxicity and antibody-dependent cellular cytotoxicity by rituximab

Published:2002-12 Issue:4 Volume:119 Page:923-929
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:

Author:

Golay Joseè,Gramigna Rosanna,Facchinetti Valeria,Capello Daniela,Gaidano Gianluca,Introna Martino

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1046/j.1365-2141.2002.03935.x/fullpdf

Reference41 articles.

1. Targeted anti-cancer therapy using rituximab, a chimeric anti-CD20 antibody (IDEC-C2B8) in the treatment of non-Hodgkin's B-cell lymphoma;Anderson;Biochemical Society Transactions,1997

2. Importance of antigen specificity for complement-mediated lysis by monoclonal antibodies;Bindon;European Journal of Immunology,1988

3. The human antibody effector function;Burton;Advances in Immunology,1992

4. BCL-6 protein expression in AIDS-related non-Hodgkin's lymphomas;Carbone;American Journal of Pathology,1997

5. CHOP chemotherapy plus rituximab compared to chop alone in elderly patients with diffuse large B cell lymphoma;Coiffier;New England Journal of Medicine,2002

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Research progress on pathogenesis and clinical treatment of neuromyelitis optica spectrum disorders (NMOSDs);Clinical Neurology and Neurosurgery;2023-08

2. Cellular Mechanisms of Etrolizumab Treatment in Inflammatory Bowel Disease;Frontiers in Pharmacology;2019-02-01

3. Novel drug therapies in myeloid leukemia: a patent review;Pharmaceutical Patent Analyst;2015-05

4. The role of complement in mAb-based therapies of cancer;Methods;2014-01

5. In vitro assessment of the effects of vedolizumab binding on peripheral blood lymphocytes;mAbs;2013-11